Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
JAMA|November 7, 1990
Intrapleural tetracycline for the prevention of recurrent spontaneous pneumothorax. Results of a Department of Veterans Affairs cooperative studyR W Light, V S O'Hara, T E Moritz, et al.
The Annals of Thoracic Surgery|August 1, 1993
Thromboembolism in patients undergoing thoracotomyS Ziomek, R C Read, H G Tobler, et al.
American Journal of Surgery|August 1, 1994
Isolated symptomatic midcervical stenosis of the internal carotid arteryT J Ranval, M M Solis, R W Barnes, et al.
Health Technology Assessment (Winchester, England)|January 7, 2011
A randomised, partially observer blind, multicentre, head-to-head comparison of a two-dose regimen of Baxter and GlaxoSmithKline H1N1 pandemic vaccines, administered 21 days apartK G Nicholson, K R Abrams, S Batham, et al.
Thorax|July 15, 2010
Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009)J S Nguyen-Van-Tam, P J M Openshaw, A Hashim, et al.
Epidemiology and Infection|August 2, 2014
Effect of ethnicity on care pathway and outcomes in patients hospitalized with influenza A(H1N1)pdm09 in the UKG A Nyland, B C McKenzie, P R Myles, et al.
The Journal of Infection|February 5, 2016
The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adultsF McGill, R S Heyderman, B D Michael, et al.
Archives of Surgery (Chicago, Ill. : 1960)|April 1, 1983
Efficacy of oral and systemic antibiotic prophylaxis in colorectal operationsR E Condon, J G Bartlett, H Greenlee, et al.
Open Forum Infectious Diseases|January 23, 2026
Controlled Human Infection of Healthy Adults With Lyophilized Neisseria lactamica Induces Asymptomatic, Immunogenic Nasopharyngeal Carriage in the United Kingdom and MaliD F Gbesemete, F Haidara, J R Laver, et al.
NPJ Vaccines|April 15, 2025
Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine developmentE Z Siegal, J M H Schoevers, J Terstappen, et al.
Pageof 16